Q4 2025 Bionano Genomics Inc Earnings Call Transcript
Key Points
- Bionano Genomics Inc (BNGO) achieved a non-GAAP gross margin of 47% for the full year 2025, up from 35% in 2024, indicating improved operational efficiency.
- The company successfully reduced its non-GAAP operating expenses by 47% year-over-year, showcasing effective cost management.
- Bionano Genomics Inc (BNGO) exceeded its original guidance by installing 32 OGM systems in 2025, surpassing the expected range of 15 to 20 installations.
- The company reported a significant increase in publications related to its technology, with 450 publications in 2025, up from 359 in 2024, reflecting growing acceptance and interest in its products.
- Bionano Genomics Inc (BNGO) has a strong cash position, with $29.6 million in cash, cash equivalents, and available-for-sale securities, extending its cash run rate into 2027.
- Revenue for the fourth quarter of 2025 was $8 million, down 3% from the previous year, indicating a decline in sales performance.
- The company experienced a 6% year-over-year decrease in the sale of nanochannel array flow cells in Q4 2025 due to supply chain constraints.
- Full-year 2025 revenue was $28.5 million, down 7% from $30.8 million in 2024, reflecting a challenging market environment.
- Software revenue declined by 22% in Q4 2025, offsetting growth in consumables and impacting overall revenue.
- Bionano Genomics Inc (BNGO) faced supply constraints for consumables in Q4 2025, which affected sales and growth potential.
Good day, and welcome to the Bionano fourth quarter and full year 2025 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Web Campbell from Gilmartin Group. Please go ahead.
Thank you, Carmen, and good afternoon, everyone. Welcome to Bionano's fourth quarter and full year 2025 financial results conference call. On the call today is Dr. Erik Holmlin, CEO and Principal Financial Officer of Bionano and Mark Adamchak, Bionano's Vice President of Accounting and Principal Accounting Officer.
After market closed today, Bionano issued a press release announcing its financial results for the fourth quarter and full year 2025. A copy of the press release can be found on the investor relations page of the company's website.
Certain statements made during this conference call may be forward-looking statements, actual results may differ materially from such statements due to several factors and risks, some of which are identified in Bionano's press
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
